UW-Madison School of Pharmacy - Pharmacology & Toxicology Faculty Research Interests

Navigation Options

Faculty Research Interests


Pharmacology/Toxicology Faculty

  • Margaret Clagett-Dame, Ph.D.
    • Therapeutic applications of vitamin A and vitamin D analogs; retinoids in embryonic and nervous system development.

  • Arash Bashirullah, Ph.D.
    • Molecular genetics of hormone action and developmental timing.

  • Ron Burnette, Ph.D.
    • Developing a molecular level mechanistic understanding of the delivery and stability of drugs by physical chemical characterization of guest-host interactions using computational chemistry and NMR.

  • Lara Collier, Ph.D.
    • Genetic approaches to identify genes involved in cancer initiation, progression, and therapy resistance.

  • Warren Heideman, Ph.D.
    • Understanding the molecular mechanisms that regulate the cellular transition from quiescence to growth; identifying critical mechanisms regulating vertebrate development that are disrupted by environmental contaminants; creating strategies for the fermentative production of biofuels.

  • Jeffrey Johnson, Ph.D.
    • Signal transduction, transcriptional control of neuroprotective genes and neurotoxicity in Parkinson’s, Alzheimer’s, Huntington’s and neuromuscular disease.

  • Paul C. Marker, Ph.D.
    • Molecular basis of prostate development and prostate cancer progression: roles of cell-cell signaling pathways and use of mouse genetics to discover novel prostatic oncogenes and tumor suppressors.

  • William Mellon, Ph.D.
    • Biochemical pharmacology of hormones. Mechanosensitive pathways of cellular function.

  • Steven G. Oakes, Ph.D.
    • Patient care and medication trends— southern Wisconsin population.

  • Richard Peterson, Ph.D.
    • Reproductive and developmental toxicity of dioxin and nanomaterials in zebrafish and mouse models.

Affiliate Faculty

  • Ralph Albrecht, Ph.D.
    • Use of inductively heated, antibody targeted, core-shell nanoparticles for selective removal of targeted cells in vitro and in vivo. Development of high resolution nanoparticle labeling systems for correlative microscopy.

  • Adnan Elfarra
    • Bioactivation of drugs, industrial chemicals, and environmental toxicants; biochemical basis for target organ selectivity; biomarkers of exposure and effect; structure and function of flavin-containing monooxygenases; glutathione-dependent prodrugs of anticancer drugs.

  • Lauren Trepanier, Ph.D., D.V.M.
    • Pharmacogenomics; metabolic basis of arylamine drug toxicity and arylamine carcinogenesis.